NCPA Reacts to GOP Health Care Legislation

PRESS RELEASE

ALEXANDRIA, Va. (March 7, 2017) National Community Pharmacists Association (NCPA) CEO B. Douglas Hoey, RPh, MBA, issued the following statement today as congressional committees prepare to consider and vote on the American Health Care Act, legislation to repeal and replace the Affordable Care Act (also referred to as "Obamacare"):

"NCPA staff is reviewing the provisions of the American Health Care Act and will continue to engage with key committees and lawmakers regarding the priorities of independent community pharmacists in health care reform legislation. These include maintaining prescription drug coverage and ensuring adequate pharmacy reimbursement for patient care as well as sufficient access to community pharmacies. In addition, bipartisan transparency provisions related to PBMs in federal exchange programs are important to retain.

"NCPA outlined in early 2017 principles for health care reform legislation. The deliberative process of Congress is lengthy and winding and NCPA staff will continue to be actively engaged throughout it every step of the way during the coming weeks and months. As part of that, NCPA has provided community pharmacists with grassroots resources to contact their members of Congress to voice support for pro-patient, pro-pharmacy policies."